Skip to main content

Table 6 Comparison between different groups as regards percentage change in drugs and costs in between 3 months & 9 months (short term) and 3 months & 18 months’ (long term) evaluations

From: Online hemodiafilteration use in children: a single center experience with a twist

   % change between
3 & 9 months
(short term effects)
% change between
3 & 18 months
(long term effects)
Variable Group Mean ±SD p Mean ±SD p
Kt/V/wk HDF 15.24 11.35 0.00 16.47 10.50 0.00
HD −0.46 4.83 0.51 5.13
Once 5.32 7.31 0.00 8.47 5.12 0.00
Twice 23.50 6.18 23.66 8.70
Epo dose/kg
(U/kg)
HDF −3.57 2.11 0.04 −11.85 10.32 0.01
HD −2.18 1.54 6.47 26.48
Once −3.58 2.18 0.9 −10.83 9.15 0.8
Twice −3.57 2.15 −12.76 11.69
(EPO/kg) /Hct Ratio HDF −10.42 11.42 0.03 −24.14 16.50 0.00
HD 0.36 12.79 7.92 36.19
Once −6.41 11.35 0.1 −20.68 20.53 0.6
Twice −13.75 10.81 −27.25 12.13
Iron Dose
(mg/month)
HDF −5.12 27.86 0.5 −21.76 25.98 0.03
HD −0.03 30.23 −0.97 31.62
Once −12.9 33.26 0.3 −22.26 33.09 0.6
Twice 1.88 21.3 −21.30 19.41
Dialysis costs
(EGP/month)
(US$/month)
HDF 42.5 (5.667) 14.27 (1.903) 0.00 42.58 (5.677) 14.29 (1.905) 0.00
HD 0.02 (0.003) 0.25 (0.033) 0.02 (0.003) 0.318 (0.0424)
Once 27.92 (3.723) 0.29 (0.039) 0.00 27.93 (3.724) 0.391 (0.052) 0.00
Twice 55.74 (7.432) 0.35 (0.0467) 55.77 (7.436) 0.54 (0.072)
Non-Dialysis costs (EGP/month) (US$/month) HDF −5.72 (−0.763) 0.96 (0.128) 0.00 −9.65 (−1.287) 8.93 (1.191) 0.00
HD −0.56 (− 0.075) 1.88 (0.251) 93.68 (12.491) 198 (26.4)
Once −4.56 (−0.608) 1.84 (0.245) 0.00 −7.11 (−0.948) 7.05 (0.94) 0.02
Twice −6.7 (−0.893) 1.46 (0.195) −11.93 (−1.591) 10.16 (1.355)
Net costs/m (EGP/month) (US$/month) HDF 21.45 (2.86) 7.20 (0.96) 0.00 19.81 (2.6410 7.32 (0.976) 0.00
HD −0.08 (−0.011) 0.70 (0.093) 9.47 (1.263) 17.36 (2.315)
Once 14.22 (1.896) 1.50 (0.2) 0.00 13.27 (1.769) 2.12 (0.283) 0.00
Twice 27.96 (3.728) 1.53 (0.204) 25.69 (3.425) 4.69 (0.625)
  1. EPO Erythropoietin, Hct hematocrit value